Epidemiological Study on the Vaccination Coverage of the Population Aged 75 Years and Over in Picardy. According to the Study of 200 Patients Followed by General Practitioners of the Somme in 2016.
NCT03132844 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2018-10-05
Summary
In France, the vaccination coverage of seniors is clearly deficient. It seems to be a cultural specificity, dating back more than 100 years, and which does not exist in Scandinavia, nor in much of the Anglo-Saxon world. Only influenza vaccination is a success for seniors. The high public health council sets the objective of immunization coverage in patients over 65 years of age to 80% whether or not the patient is benefiting from an exonerative ALD. The data collections carried out with the various pension funds objective have a lower immunization coverage with a rate ranging from 48.8 to 64%. Thus any medical consultation should be an opportunity to update the vaccination schedule of adults and the elderly.
Conditions
- Vaccination
- Elderly
Interventions
- OTHER
-
Analysis records of patients over 75 years of age
Demonstrate the percentage of patients over 75 years of age attending general medicine in the Somme, with an up-to-date vaccination schedule, in view of the HAS 2016 recommendations, for the following vaccines: DTp, influenza, pneumococcus, shingles.
Sponsors & Collaborators
-
Centre Hospitalier Universitaire, Amiens
lead OTHER
Eligibility
- Min Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-17
- Primary Completion
- 2018-03-10
- Completion
- 2018-03-10
Countries
- France
Study Locations
More Related Trials
-
Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in Korea
NCT01215669 ·Status: COMPLETED ·Phase: PHASE4
-
Prospective Cohort Study to Evaluate Safety/Immunogenicity of Butantan Influenza Vaccine in Healthy Adults/Elderly
NCT02313740 ·Status: COMPLETED
-
Study to Demonstrate the Lot-to-lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate
NCT00321763 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults
NCT00386698 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population
NCT00318058 ·Status: COMPLETED ·Phase: PHASE1
-
Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM Vaccine
NCT00554333 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenecity and Safety of VaccinemRNA-1273 in Elderly Volunteers (Over 65 y) Compared to Younger Ones (18-45y)
NCT04748471 ·Status: UNKNOWN ·Phase: PHASE2
-
Protection From Influenza: Determining the Impact of Prior Infection
NCT03004040 ·Status: UNKNOWN
-
Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults
NCT02154308 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly
NCT00386113 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Immunogenicity & Safety of an Investigational Influenza Vaccine in Adults
NCT00975884 ·Status: COMPLETED ·Phase: PHASE3
-
Inpatient Influenza Surveillance
NCT00419861 ·Status: COMPLETED
-
Systems Biology of Trivalent Influenza Vaccine (TIV) in Young and Elderly
NCT01232868 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults
NCT05012800 ·Status: UNKNOWN ·Phase: PHASE4
-
Influenza Vaccine in Children With Asthma
NCT04086628 ·Status: UNKNOWN
-
Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)
NCT01424371 ·Status: UNKNOWN
-
Safety and Immunogenicity of One Dose of an Inactivated Trivalent Sub-unit Influenza Vaccine Administered to Non-elderly Adult and Elderly Subjects
NCT01357265 ·Status: COMPLETED ·Phase: PHASE2
-
Elderly Influenza Vaccine Immunogenicity Substudy
NCT00170482 ·Status: COMPLETED
-
Comparison of 4 Influenza Vaccines in Seniors
NCT01368796 ·Status: COMPLETED ·Phase: PHASE4
-
Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)
NCT03392207 ·Status: COMPLETED
-
Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and Older
NCT00848848 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of a Brief Intervention for Acceptance of Influenza Vaccine in the Primary Care Setting
NCT04568785 ·Status: COMPLETED ·Phase: NA
-
Th1 Response to Influenza: Aging and Vaccine Efficacy
NCT00396305 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine in Older Adults
NCT01014806 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of a Monovalent Inactivated Influenza H3N2 Variant (H3N2v) Vaccine in Adult and Elderly Populations
NCT01746082 ·Status: COMPLETED ·Phase: PHASE2